Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis

Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical gastroenterology and hepatology 2012-07, Vol.10 (7), p.820-821
Hauptverfasser: Rodríguez–Castro, Kryssia Isabel, MD, Senzolo, Marco, MD, PhD, Sartori, Maria Teresa, MD
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Female
Gastroenterology and Hepatology
Humans
Liver Cirrhosis - complications
Male
Portal Vein - pathology
Venous Thrombosis - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 821
container_issue 7
container_start_page 820
container_title Clinical gastroenterology and hepatology
container_volume 10
creator Rodríguez–Castro, Kryssia Isabel, MD
Senzolo, Marco, MD, PhD
Sartori, Maria Teresa, MD
description
doi_str_mv 10.1016/j.cgh.2012.02.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1021980102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1542356512002261</els_id><sourcerecordid>1021980102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-525a74705c7d08e20cde4728cedef41075cdbb8ac0718ee59732b77c595198693</originalsourceid><addsrcrecordid>eNp9kU9rGzEQxUVoSdIkH6CXssde7Gq0K2uXQiGY_gNDAnUSchJa7dgrd71yJG3A376z2M0hh8DACPTeY-Y3jH0EPgUOsy-bqV23U8FBTPlYcMLOQRZiohQU747vXM7kGfsQ44ZzURWVOmVnQuSlEjI_Z483u-S2pssW2K9Tm_lVdt0nZ71ZD53pU7ZsMZjdPnN9NnchtJ4-s1uTHPYpZg-OPLc-JEq4R9Is2-C3tY8uXrL3K9NFvDr2C3b34_ty_muyuPn5e369mNhCQppIIY0qFJdWNbxEwW2DhRKlxQZXBXAlbVPXpbFcQYkoK5WLWikrKwlVOavyC_b5kLsL_mnAmPTWRYsdTY9-iBqIS1VyaiSFg9QGH2PAld4FWj7sSaRHonqjiageiWo-FpDn0zF-qLfYvDj-IyTB14MAaclnh0FHS3BofhfQJt1492b8t1du27neWdP9xT3GjR9CT_Q06EgG_Wc86XhREHRNMYP8H2TOmqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1021980102</pqid></control><display><type>article</type><title>Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rodríguez–Castro, Kryssia Isabel, MD ; Senzolo, Marco, MD, PhD ; Sartori, Maria Teresa, MD</creator><creatorcontrib>Rodríguez–Castro, Kryssia Isabel, MD ; Senzolo, Marco, MD, PhD ; Sartori, Maria Teresa, MD</creatorcontrib><identifier>ISSN: 1542-3565</identifier><identifier>EISSN: 1542-7714</identifier><identifier>DOI: 10.1016/j.cgh.2012.02.021</identifier><identifier>PMID: 22387253</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anticoagulants - administration &amp; dosage ; Anticoagulants - adverse effects ; Female ; Gastroenterology and Hepatology ; Humans ; Liver Cirrhosis - complications ; Male ; Portal Vein - pathology ; Venous Thrombosis - drug therapy</subject><ispartof>Clinical gastroenterology and hepatology, 2012-07, Vol.10 (7), p.820-821</ispartof><rights>AGA Institute</rights><rights>2012 AGA Institute</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-525a74705c7d08e20cde4728cedef41075cdbb8ac0718ee59732b77c595198693</citedby><cites>FETCH-LOGICAL-c451t-525a74705c7d08e20cde4728cedef41075cdbb8ac0718ee59732b77c595198693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cgh.2012.02.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22387253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodríguez–Castro, Kryssia Isabel, MD</creatorcontrib><creatorcontrib>Senzolo, Marco, MD, PhD</creatorcontrib><creatorcontrib>Sartori, Maria Teresa, MD</creatorcontrib><title>Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis</title><title>Clinical gastroenterology and hepatology</title><addtitle>Clin Gastroenterol Hepatol</addtitle><subject>Anticoagulants - administration &amp; dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Liver Cirrhosis - complications</subject><subject>Male</subject><subject>Portal Vein - pathology</subject><subject>Venous Thrombosis - drug therapy</subject><issn>1542-3565</issn><issn>1542-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9rGzEQxUVoSdIkH6CXssde7Gq0K2uXQiGY_gNDAnUSchJa7dgrd71yJG3A376z2M0hh8DACPTeY-Y3jH0EPgUOsy-bqV23U8FBTPlYcMLOQRZiohQU747vXM7kGfsQ44ZzURWVOmVnQuSlEjI_Z483u-S2pssW2K9Tm_lVdt0nZ71ZD53pU7ZsMZjdPnN9NnchtJ4-s1uTHPYpZg-OPLc-JEq4R9Is2-C3tY8uXrL3K9NFvDr2C3b34_ty_muyuPn5e369mNhCQppIIY0qFJdWNbxEwW2DhRKlxQZXBXAlbVPXpbFcQYkoK5WLWikrKwlVOavyC_b5kLsL_mnAmPTWRYsdTY9-iBqIS1VyaiSFg9QGH2PAld4FWj7sSaRHonqjiageiWo-FpDn0zF-qLfYvDj-IyTB14MAaclnh0FHS3BofhfQJt1492b8t1du27neWdP9xT3GjR9CT_Q06EgG_Wc86XhREHRNMYP8H2TOmqQ</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Rodríguez–Castro, Kryssia Isabel, MD</creator><creator>Senzolo, Marco, MD, PhD</creator><creator>Sartori, Maria Teresa, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis</title><author>Rodríguez–Castro, Kryssia Isabel, MD ; Senzolo, Marco, MD, PhD ; Sartori, Maria Teresa, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-525a74705c7d08e20cde4728cedef41075cdbb8ac0718ee59732b77c595198693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anticoagulants - administration &amp; dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Liver Cirrhosis - complications</topic><topic>Male</topic><topic>Portal Vein - pathology</topic><topic>Venous Thrombosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodríguez–Castro, Kryssia Isabel, MD</creatorcontrib><creatorcontrib>Senzolo, Marco, MD, PhD</creatorcontrib><creatorcontrib>Sartori, Maria Teresa, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodríguez–Castro, Kryssia Isabel, MD</au><au>Senzolo, Marco, MD, PhD</au><au>Sartori, Maria Teresa, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis</atitle><jtitle>Clinical gastroenterology and hepatology</jtitle><addtitle>Clin Gastroenterol Hepatol</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>10</volume><issue>7</issue><spage>820</spage><epage>821</epage><pages>820-821</pages><issn>1542-3565</issn><eissn>1542-7714</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22387253</pmid><doi>10.1016/j.cgh.2012.02.021</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1542-3565
ispartof Clinical gastroenterology and hepatology, 2012-07, Vol.10 (7), p.820-821
issn 1542-3565
1542-7714
language eng
recordid cdi_proquest_miscellaneous_1021980102
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Female
Gastroenterology and Hepatology
Humans
Liver Cirrhosis - complications
Male
Portal Vein - pathology
Venous Thrombosis - drug therapy
title Optimal Length of Anticoagulant Therapy in Cirrhotic Patients With Portal Vein Thrombosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimal%20Length%20of%20Anticoagulant%20Therapy%20in%20Cirrhotic%20Patients%20With%20Portal%20Vein%20Thrombosis&rft.jtitle=Clinical%20gastroenterology%20and%20hepatology&rft.au=Rodr%C3%ADguez%E2%80%93Castro,%20Kryssia%20Isabel,%20MD&rft.date=2012-07-01&rft.volume=10&rft.issue=7&rft.spage=820&rft.epage=821&rft.pages=820-821&rft.issn=1542-3565&rft.eissn=1542-7714&rft_id=info:doi/10.1016/j.cgh.2012.02.021&rft_dat=%3Cproquest_cross%3E1021980102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1021980102&rft_id=info:pmid/22387253&rft_els_id=1_s2_0_S1542356512002261&rfr_iscdi=true